ERC Pharma
1002.131.150 · rovalta.com · 22/09/2026
ACTIVE
ERC Pharma
Financial year 2024 · closed on 31/12/2024
Net result
-152 k €
Gross margin
-49,3 k €
Equity
-52 k €
Overview
What does ERC Pharma do?
ERC Pharma is a Public limited company incorporated in 2023. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gembloux.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 1002.131.150
Incorporation
09/11/2023
Legal form
Public limited company
Registered office
Rue Jean Sonet,Isnes 10
5032 Gembloux · WallonieSee on map
5032 Gembloux · WallonieSee on map
Contributed capital
100 000,00 €
Latest accounts
31/12/2024
Activities (NACE)
Contacts
2 public details availableLog in to view
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 1 financial year
| 2024 | |
|---|---|
| Income statement | |
| Gross margin | -49,3 k € |
| EBITDA | -49,4 k € |
| Operating result | -71,2 k € |
| Net result | -152 k € |
| Balance sheet | |
| Equity | -52 k € |
| Total assets | 3,7 M € |
| Cash | 35,6 € |
| Debts | 3,8 M € |
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
ERC BELGIUM● Active | 0895.963.165 |
Innovative Coating Solutions● Active | 0673.500.890 |
STRATICELL SCREENING TECHNOLOGIES● Bankrupt | 0872.072.956 |
Financials
Annual accounts
Full financial information
| 2024 | |
|---|---|
| Type of account | Micro model |
| Start of the financial year | 09/11/2023 |
| Closing of the financial year | 31/12/2024 |
| Length of the financial year | 14 months |
| Filing date | 26/08/2025 |
| General meeting | 27/06/2025 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
1 filing with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 27/06/2025 | 26/08/2025 | French |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-152 k €
- 09/11/2023IncorporationPublic limited company